The report uses the example of innovator multinational pharmaceutical companies to make the point that it is their consistent investment in R&D that has sustained their business, validating the need for continuously enriching the research pipeline.

Economists and commentators agree that India has the potential to become a global centre for innovative drug development and production. It possesses the talent and resources to do this successfully and has the pharmaceutical base to support such activity. However, for this to become a reality, India must create the enabling conditions that ensure that products of innovation receive full patent protection. Without this protection neither Indian nor multinational companies would be willing to make the necessary investment in research and development. In order to ‘Create and Innovate’ in India, the current IPR environment requires significant re-adjustment and patent protection is a necessary precondition.Fashion Style, Style Shoes Online, Ladies Shoes Style, New Style New Balance, Boot Style Sandals Products